A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. TG Therapeutics Inc’s current trading price is -4.11% away from its 52-week high, while its distance from the 52-week low is 262.82%. The stock’s price range for this time frame has been between $6.98 and $26.41. The trading volume of the company’s shares in the Healthcare reached around 1.97 million for the day, which was evidently lower than the average daily volume of 3.54 million over the last three months.
In terms of market performance, TG Therapeutics Inc had a somewhat regular. The highest value for the stock in the past year was $26.41 on 09/18/24, while the lowest value was $6.98 on 10/30/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
How Financial Performance Impacts Market Capitalization
TG Therapeutics Inc (TGTX) has experienced a quarterly rise of 28.16% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.92B and boasts a workforce of 264 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 21.41, with a change in price of +9.41. Similarly, TG Therapeutics Inc recorded 3,194,204 in trading volume during the last 100 days, posting a change of +59.52%.
How TGTX’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for TGTX stands at 0.63. Similarly, the long-term debt-to-equity ratio is also 0.63.
TGTX Stock Stochastic Average
The raw stochastic average for TG Therapeutics Inc over the last 50 days is presently at 77.55%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 83.54%. Further, the company’s Stochastic %K and %D values for the last 20 days were 76.40% and 66.55%, respectively.
TGTX Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The metric has seen a significant gain of 48.27% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 85.40%. Over the past 30 days, the price of TGTX has fallen by 8.27%. And in the last five days, it has surged by 4.43%.
